Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

Is axillary node dissection beneficial in patients with T1 or T2 breast cancer whose initial therapy is lumpectomy and tangential breast irradiation? The authors performed a randomized controlled ...

MIAMI BEACH -- The surgical dogma favoring axillary dissection in breast cancer continues to give way to more selective data-driven strategies that allow more women to avoid axillary surgery, an ...

Axillary lymph node dissection (ALND) is a procedure to remove lymph nodes in the underarm area when breast cancer has spread, aiming to prevent further spread and recurrence. The procedure involves ...

Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...

February 9, 2011 — In certain women with early-stage breast cancer and positive nodes, sentinel lymph node dissection (SLND) does not result in inferior survival, compared with axillary lymph node ...

A new procedure improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating ...

Axillary lymph node dissection did not improve survival outcomes in a cohort of women with T1-T2 breast cancer who had received sentinel node dissection, according to study results. Eligible women had ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Long-term survival outcomes from the ACOSOG Z0011 trial supported the initial finding of ...